Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a for rhinovirus infection in primary hypogammaglobulinemia
2015-001072-22Phase 2Completed
- Sponsor
- Turku University Hospital
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in rhinoviral infection, sponsored by Turku University Hospital. Started Jan 2016; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
rhinoviral infection
Beyond the preview
Go deeper on 2015-001072-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001072-22.